leisure time -WSS

leisure time

author：fashion 2025-08-11 11:42:27 - browse：57

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： How one patient went off dialysis — and others can too

WSS

What AAP's gender

How Long Island became the ‘eugenics capital of the world’

How to make AI work for medicine

Mindstrong's demise and the future of mental health care

Inequities make cancer less preventable for women: report

Kaiser Permanente unions announce official strike date

hotspot

leisure time

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Did you have Obamacare on your GOP debate bingo card?

Dobbs anniversary: the lost opportunity of abortion as health care

How Long Island became the ‘eugenics capital of the world’

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel gives mixed vote on blood pressure devices

What does generative AI mean for health care? We asked experts

FDA advisers vote against ALS treatment from BrainStorm

Wildfire smoke exposes gaps in outdoor worker protections

How the Dana

leisure time

How Long Island became the ‘eugenics capital of the world’

Departing Stanford president retracts two papers

Mindstrong's demise and the future of mental health care

2024 GOP presidential candidates spar over abortion in debate

Ionis has late

How one patient went off dialysis — and others can too

knowledge

leisure time

entertainment

explore